| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/25/2001 | CA2388846A1 Novel composition and use |
| 05/23/2001 | EP1101112A2 Leptin-mediated gene-induction |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100801A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 05/23/2001 | EP1100790A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |
| 05/23/2001 | EP1100787A1 Lipid-lowering quinazoline derivative |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100771A1 Compounds and compositions for delivering active agents |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100532A2 Methods of using lanreotide, a somatostatin analogue |
| 05/23/2001 | EP1100530A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 05/23/2001 | EP1100522A1 Pulmonary delivery of active agents |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100486A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100484A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100469A1 Rapidly disintegrable solid preparation |
| 05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 05/23/2001 | EP0722431B1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 05/23/2001 | EP0669827B1 Compositions for the regulation of cytokine activity |
| 05/23/2001 | CN1296489A Phosphonic diester derivatives |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296485A Substituted indolealkanoic acids |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/23/2001 | CN1295859A Process for preparation of medicine to treat diabetes |
| 05/23/2001 | CN1295836A Jinlan Chinese herbal medicine prescription for treating diabetes |
| 05/23/2001 | CN1066150C Bridged indole as matrix metalloprotease inhibitors |
| 05/22/2001 | US6236946 Nuclear receptor ligands and ligand binding domains |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235923 Retinoids and cell differentiation |
| 05/22/2001 | US6235909 Preparation of is-[1A,2B,3B,4A(S*)]-4-[7-[[1-(3-chloro-2-Thienyl)methyl]amino]-3H-imidazo [4,5-B]pyridin-3-YL]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide |
| 05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
| 05/22/2001 | US6235770 Anticholesterol agents |
| 05/22/2001 | US6235763 Therapy for eating disorders |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235734 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 05/22/2001 | US6235730 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235481 Polynucleotides encoding calpain 10 |
| 05/22/2001 | US6235315 Solution of lycopene, solvent and emulsifier, mixing and removal of solvent to form dry powder |
| 05/22/2001 | US6235311 Pharmaceutical composition containing a combination of a statin and aspirin and method |
| 05/21/2001 | WO2001032637A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
| 05/21/2001 | CA2388200A1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics |
| 05/17/2001 | WO2001035096A2 Diseases associated with altered mitochondrial function |
| 05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034781A2 Lytic enzymes useful for treating fungal infections |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034638A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034610A1 Polycycloalkylpurines as adenosine receptor antagonists |
| 05/17/2001 | WO2001034607A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 05/17/2001 | WO2001034605A1 SUBSTITUTED 2-ARYL-3-(HETEROARYL)-IMIDAZO[1,2-a]PYRIMIDINES, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS |
| 05/17/2001 | WO2001034604A2 Adenosine receptor antagonists and methods of making and using the same |
| 05/17/2001 | WO2001034601A2 Imidazopyridine derivatives as phosphodiesterase vii inhibitors |
| 05/17/2001 | WO2001034593A1 Compound with growth hormone releasing properties |
| 05/17/2001 | WO2001034586A2 Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-ht1a activity |
| 05/17/2001 | WO2001034579A1 Alkoxyiminoalkanoic acid derivatives |
| 05/17/2001 | WO2001034570A1 Nitrogenous heterocycle derivatives |
| 05/17/2001 | WO2001034562A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 05/17/2001 | WO2001034200A1 Body weight gain inhibitors |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034159A1 Protease inhibitors |
| 05/17/2001 | WO2001034157A1 Protease inhibitors |
| 05/17/2001 | WO2001034148A1 Solid preparations for oral use |
| 05/17/2001 | WO2001034140A1 Pharmaceutical formulation |
| 05/17/2001 | WO2001034119A2 Inhibitors of crystallization in a solid dispersion |
| 05/17/2001 | WO2001034094A2 Novel compounds to treat diabetes and associated conditions |
| 05/17/2001 | WO2001033977A1 Product and method for control of obesity |
| 05/17/2001 | WO2001033976A1 Methods for regulating blood glucose and appetite suppression in type 2 diabetics |
| 05/17/2001 | WO2001033975A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 05/17/2001 | WO2001028353A8 Protein hydrolysates produced with the use of marine proteases |
| 05/17/2001 | WO2001024796A8 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 05/17/2001 | WO2001019356A3 High lipid diet |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001009116A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)- 2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001005390A3 Method for treating chronic pain using mek inhibitors |
| 05/17/2001 | WO2001001973A8 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 05/17/2001 | WO2000041484A3 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 05/17/2001 | WO2000040613A9 Insulin-like growth factor (igf) i mutant variants |
| 05/17/2001 | DE19954707A1 Imidazolverbindungen als Phosphodiesterase VII-Hemmer Imidazole compounds as phosphodiesterase VII inhibitor |
| 05/17/2001 | CA2390932A1 Body weight gain inhibitors |
| 05/17/2001 | CA2390928A1 Alkoxyiminoalkanoic acid derivatives |
| 05/17/2001 | CA2390880A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |